Abstract: The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.
Type:
Grant
Filed:
October 28, 2008
Date of Patent:
May 29, 2012
Assignee:
Omega Bio-Pharma (I.P.3) Limited
Inventors:
Bill Piu Chan, Gary Kwan Po Wong, Jinxian Xu, Francis Chi
Abstract: The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications.
Type:
Grant
Filed:
November 5, 2008
Date of Patent:
February 22, 2011
Assignee:
Omega Bio-Pharma (I.P.3) Limited
Inventors:
Bill Piu Chan, Gary Kwan Po Wong, Jinxian Xu, Francis Chi
Abstract: The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications.
Type:
Grant
Filed:
April 29, 2005
Date of Patent:
July 20, 2010
Assignee:
Omega Bio-Pharma (I.P.3) Limited
Inventors:
Bill Piu Chan, Gary Kwan Po Wong, Jinxian Xu, Francis Chi
Abstract: The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.
Type:
Grant
Filed:
December 20, 2004
Date of Patent:
October 28, 2008
Assignee:
Omega Bio-Pharma (I.P.3) Limited
Inventors:
Bill Piu Chan, Gary Kwan Po Wong, Jinxian Xu, Francis Chi